Author:
Hajjar Roger J.,Gwathmey Judith K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference26 articles.
1. Baumann G, Ningel K, Permanetter B. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1989;13(5):730?738.
2. Benedikter L and Mey T. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115, a new positive inotropic agent with additional vasodilating activity in normal subjects. Arzneim Forsch (Drug Res) 1981;31:239?242.
3. Renard M, Walter M, Liebens I, et al. Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent. Chest 1988;93(6):1159?1164.
4. Thormann J, Kramer W, Kindler M, et al. Comparative efficacy of the new cardiotonic agent DPI 201?106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and ?on-line? MVO2 assessment. J Cardiovasc Pharmacol 1986;8(4):749?757.
5. Thormann J, Schlepper M, Kramer W, et al. Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia. J Am Coll Cardiol 1983;2(2):332?337.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献